analyst
MY
NASDAQ · MYGN
Myriad Genetics, Inc.
Healthcare · Medical - Diagnostics & Research
$3.18
Down-$0.04 (-1.24%)
Updated Sep 2, 2026, 8:28 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 680.86M
- P/E ratio
- -1.71
- Dividend yield
- 0.00%
- 52-week range
- $2.74 – $8.59
- Volume
- 3.03M
- Avg. volume
- 1.22M
Price performance
MYGN price history
1M range · 21 trading sessions · Daily adjusted prices
MYGN closed at $3.18 after 21 trading sessions, up 0.32% for the selected period.
- Last close
- $3.18
- Period change
- +0.32%
- Period low
- $2.87
- Period high
- $3.26
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 1, 2026 | $2.95 | $3.215 | $2.92 | $3.18 | 3.03M |
| Aug 31, 2026 | $3.15 | $3.26 | $3.04 | $3.22 | 1.54M |
| Aug 28, 2026 | $3.15 | $3.20 | $3.07 | $3.16 | 1.43M |
| Aug 27, 2026 | $3.11 | $3.2699 | $3.09 | $3.18 | 1.28M |
| Aug 26, 2026 | $3.18 | $3.19 | $3.085 | $3.12 | 1.29M |
| Aug 25, 2026 | $3.06 | $3.21 | $3.01 | $3.19 | 1.76M |
| Aug 24, 2026 | $3.20 | $3.20 | $3.00 | $3.05 | 1.35M |
| Aug 21, 2026 | $3.22 | $3.255 | $3.12 | $3.20 | 1.28M |
| Aug 20, 2026 | $3.17 | $3.295 | $3.141 | $3.22 | 1.93M |
| Aug 19, 2026 | $2.95 | $3.20 | $2.9225 | $3.19 | 2.19M |
| Aug 18, 2026 | $3.005 | $3.01 | $2.835 | $2.87 | 2.04M |
| Aug 17, 2026 | $3.01 | $3.085 | $2.97 | $3.05 | 1.39M |
| Aug 14, 2026 | $3.17 | $3.18 | $3.01 | $3.03 | 1.56M |
| Aug 13, 2026 | $3.24 | $3.2762 | $3.145 | $3.17 | 1.62M |
| Aug 12, 2026 | $3.25 | $3.25 | $3.13 | $3.23 | 1.16M |
| Aug 11, 2026 | $3.23 | $3.27 | $3.145 | $3.22 | 1.49M |
| Aug 10, 2026 | $3.20 | $3.325 | $3.20 | $3.25 | 1.38M |
| Aug 7, 2026 | $3.22 | $3.29 | $3.18 | $3.26 | 1.44M |
| Aug 6, 2026 | $3.155 | $3.21 | $3.015 | $3.18 | 2.54M |
| Aug 5, 2026 | $3.12 | $3.26 | $3.045 | $3.15 | 3.71M |
| Aug 4, 2026 | $3.00 | $3.23 | $3.00 | $3.17 | 3.5M |
Latest MYGN news
The latest Smart Investors Daily articles mentioning MYGN.
Stock researchCompany · Dividend
Loading stock research…

